WiserTogether has completes a Series B funding of USD9 million led by Martin Ventures and Merck Global Health Innovation Fund (Merck GHI).
The company's founder and CEO, Shub Debgupta, as well as all prior institutional investors, including Grotech Ventures, Harbert Venture Partners, 7Wire Ventures and Blue Heron Capital, participated in the round.
"With the addition of Merck GHI and Martin Ventures and our existing investors, WiserTogether is thrilled to have some of the smartest and most sophisticated investors from every major category of the healthcare industry represented and working together to achieve our exciting vision," says Shub Debgupta, chief executive officer, WiserTogether.
WiserTogether's personalised healthcare comparison software enables consumers to compare over 4,000 of the highest cost treatments using personal, financial and clinical factors and to engage with the right treatment.
"We believe that WiserTogether's consumer decision support platform will help consumers more fully understand the impact of health treatment options, and ultimately drive healthcare providers to better focus the delivery of services around these patient-centred needs and preferences," says Charlie Martin, chief executive officer, Martin Ventures.
WiserTogether will use the funds to scale its operations and expand its customer base across key sectors of healthcare.
"This is an exciting time in healthcare and for WiserTogether. To win in healthcare today, and in the future, you must support and enable better decisions. Those who better understand (and predict) those decisions will have a substantial advantage over the competition and will benefit from the emerging payment structures," Debgupta says.
